TRICIDA, INC.

Profile

Company Names

TRICIDA, INC.

Addresses

7000 SHORELINE COURT, SUITE 201, SOUTH SAN FRANCISCO, CA 94080

1430 O-BRIEN DRIVE, SUITE F, MENLO PARK, CA 94025

Phone Numbers

415-429-7800
415-988-1093

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$103,124,764.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2017-11-07 
$57,559,996.00 
$57,559,996.00 
$0.00 
Equity 
3
2016-07-12 
$23,908,857.00 
$55,500,000.00 
$31,591,143.00 
Equity 
2
2015-02-13 
$17,141,667.00 
$30,250,000.00 
$13,108,333.00 
Equity 
1
2013-12-18 
$4,514,244.00 
$13,164,243.00 
$8,649,999.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
ALPERN 
DIRECTOR
TRICIDA, INC.
DAVID 
 
BONITA 
DIRECTOR
VIEWRAY INC   |  ENOBIA PHARMA CORP   |  LOXO ONCOLOGY, INC.   |  TRICIDA, INC.   |  VIEWRAY, INC.   |  ACUTUS MEDICAL, INC.   |  SI-BONE, INC.   |  PRELUDE THERAPEUTICS INC.   |  PRELUDE THERAPEUTICS INC   |  IMARA INC.   |  ORBIMED PARTNERS II, L.P.   |  ORBIMED GLOBAL HEALTHCARE ASSOCIATES FUND, L.P.   |  ORBIMED GLOBAL HEALTHCARE FUND, L.P.   |  TREELINE BIOSCIENCES, INC.   |  IKENA ONCOLOGY, INC.   |  ADELA, INC.   |  THROMBOLEX, INC.
JERRY 
 
BUYSSE 
EXECUTIVE OFFICER
TRICIDA, INC.
SANDRA 
 
COUFAL 
DIRECTOR
MINIVAX, INC.   |  TRICIDA, INC.   |  SAFETY SPOT INC.   |  BIOAESTHETICS CORP
EDWARD 
 
HEJLEK 
EXECUTIVE OFFICER
TRICIDA, INC.
DAVID 
 
HIRSCH 
DIRECTOR
NCRX OPTICAL SOLUTIONS INC   |  PRECISION THERAPEUTICS INC   |  TURIYA MEDIA, INC.   |  CIVITAS THERAPEUTICS, INC.   |  COLLEGIUM PHARMACEUTICAL INC   |  SONGZA, INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  METAMORPHIC VENTURES II, L.P.   |  METAMORPHIC VENTURES II-A, L.P.   |  VOYAT INC.   |  LAUNCHKEY, INC.   |  ONEX YORK CO-INVEST LP   |  COLLEGIUM PHARMACEUTICAL, INC   |  MOVE LOOT, INC.   |  METAMORPHIC VENTURES FD, LLC   |  VELICEPT THERAPEUTICS, INC.   |  GROOP INTERNET PLATFORM INC.   |  ZAVANTE THERAPEUTICS, INC.   |  TRICIDA, INC.   |  MOLECULAR TEMPLATES, INC.   |  POSEIDA THERAPEUTICS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  SWIFT HOLDCO LTD   |  WKCGRG HOLDINGS, INC.
GERRIT 
 
KLAERNER 
EXECUTIVE OFFICER, DIRECTOR
RENNOVIA INC   |  RELYPSA INC   |  TRICIDA, INC.
CLAIRE 
 
LOCKEY 
EXECUTIVE OFFICER
RELYPSA INC   |  TRICIDA, INC.
MELISSA 
 
MIKSCH 
EXECUTIVE OFFICER
TRICIDA, INC.
GEOFFREY 
 
PARKER 
EXECUTIVE OFFICER
ANACOR PHARMACEUTICALS INC   |  ANACOR PHARMACEUTICALS, INC.   |  TRICIDA, INC.   |  BETTER THERAPEUTICS, INC.
WILHELM 
 
STAHL 
EXECUTIVE OFFICER
RELYPSA INC   |  TRICIDA, INC.
KLAUS 
 
VEITINGER 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.   |  BIOLEX THERAPEUTICS, INC.   |  RELYPSA INC   |  INTERCEPT PHARMACEUTICALS INC   |  SYMBIOMIX THERAPEUTICS, LLC   |  TRICIDA, INC.   |  CRANIOVATION, INC.   |  SPARROW PHARMACEUTICALS, INC.   |  NEUROGASTRX, INC.   |  ALPHEUS MEDICAL, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-11-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-07 
2016-07-25
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-12 
2015-02-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-02-13 
2014-01-30
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-18 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#